University OF Texas/texas AM Investment Management Co., 10% Owner at Aileron Therapeutics, Inc. (ALRN), sold 12,315 shares at $3.30 ($41K) on 2024-06-05, disclosed to the SEC on 2024-06-07.
Open-market sale of $41k ALRN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.30 | 6,291 | $21K | 51.2% |
| 2 | $3.27 | 1,100 | $4K | 8.9% |
| 3 | $3.30 | 3,184 | $11K | 25.9% |
| 4 | $3.25 | 1,564 | $5K | 12.5% |
| 5 | $3.30 | 176 | $581 | 1.4% |
| Total | $3.29 avg | 12,315 |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateSilver Point Specialty Lending Fund | BUY | 2026-03-02 | $6.8M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY |
| $41K |
| 100% |
| 2026-02-02 |
| $9.7M |
| — |
| Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-12-29 | $8.6M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-11-26 | $8.8M | — | Filing → |
| PrivateSilver Point Specialty Lending Fund | BUY | 2025-10-27 | $7.6M | — | Filing → |